Transforming Biopharmaceutical Care Through the US Plasma Fractionation Market
The US plasma fractionation market is on the brink of a remarkable transformation, with projections indicating a surge in market size from $8.5 billion in 2024 to an astonishing $17 billion by 2035. This growth trajectory aligns with a compound annual growth rate (CAGR) of 6.5%, highlighting a robust demand for plasma-derived products across healthcare sectors. The increasing prevalence of...
0 Commentaires 0 Parts 39 Vue 0 Aperçu